| |
| Device | SYNVISC (HYLAN G-F 20) AND SYNVISC-ONE (HYLAN G-F 20) |
| Generic Name | Acid, hyaluronic, intraarticular |
| Applicant | Sanofi Genzyme Corp. 450 Water St. Cambridge, MA 02141 |
| PMA Number | P940015 |
| Supplement Number | S018 |
| Date Received | 04/22/2010 |
| Decision Date | 11/24/2010 |
| Product Code |
MOZ |
| Advisory Committee |
Orthopedic |
| Supplement Type | 135 Review Track For 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement APPROVAL FOR THE INTRODUCTION OF FEDEGARI AUTOCLAVE AS AN ADDITIONAL AUTOCLAVE IN THE MANUFACTURING PROCESS. |